ReproCELL Incorporated (FRA:6RC)

Market Cap	73.91M -26.4%
Revenue (ttm)	12.41M -18.7%
Net Income	-2.35M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	0.5950
Previous Close	0.5900
Day's Range	0.5950 - 0.5950
52-Week Range	0.4420 - 0.9550
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 101
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6RC

Financial Performance

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error